Filing Details
- Accession Number:
- 0001181431-13-028437
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-16 18:07:24
- Reporting Period:
- 2013-05-14
- Filing Date:
- 2013-05-16
- Accepted Time:
- 2013-05-16 18:07:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1534287 | Bioamber Inc. | BIOA.U | Industrial Organic Chemicals (2860) | 980601045 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1575522 | Sicar Sca Partners Capital Naxos | 40 Boulevard Joseph Ii, L-1840 N4 | No | No | Yes | No | |
1575936 | S.a. Naxamber | 40 Boulevard Joseph Ii, L-1840 N4 | No | No | Yes | No | |
1575976 | R.l. S.a Managers Capital Naxos | 40 Boulevard Joseph Ii L-1840 N4 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-05-14 | 600,000 | $0.00 | 3,970,815 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock Warrants (right to buy) | Acquisiton | 2013-05-14 | 600,000 | $0.00 | 300,000 | $11.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
600,000 | 2013-08-08 | 2017-05-09 | No | 4 | P | Direct |
Footnotes
- The reported securities are included within 600,000 Units purchased by the reporting person for $10 per Unit in connection with the Issuer's initial public offering. Each Unit consists of one share of common stock and one warrant to purchase half of one share of common stock. The Units currently trade on the NYSE. The common stock and warrants comprising the Units will begin trading separately on June 10, 2013, at which time trading of the Units will be suspended and the Units will be de-listed. Each warrant will be exercisable during the period commencing on August 8, 2013 and ending at 5:30 p.m. on May 9, 2017 at an exercise price of $11.00 per whole share of common stock.
- Naxamber, S.A. ("Naxamber") directly owns 3,970,815 shares of Common Stock (inclusive of common stock included within 600,000 Units purchased). Naxamber is wholly-owned by Naxos Capital Partners SCA SICAR ("Naxos Partners"). The General Partner of Naxos Partners is Naxos Capital Managers S.a r.l. ("Naxos Managers"). Therefore, each of Naxamber, Naxos Partners and Naxos Managers may be deemed to beneficially own the shares of Common Stock directly owned by Naxamber.